Chantsalmaa Davgadorj
Wuxi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Etiology and Prognostic Criteria for Liver Failure in Southeast China: A Multicenter Retrospective Cohort Study Between 2018 and 2020.
Journal: Gastroenterology research and practice
Published: October 09, 2023
Corrigendum: Novel molecular therapeutics targeting signaling pathway to control hepatitis B viral infection.
Journal: Frontiers in cellular and infection microbiology
Published: July 04, 2023
Analyze the clinical characteristics of mild and severe SARS-CoV-2 infected patients based on the local Omicron variant epidemic
Journal: Zhonghua wei zhong bing ji jiu yi xue
Published: March 07, 2023
Predictive Value of Baseline Serum Marker Levels for the Effect of Interferon Therapy in Patients With Chronic Hepatitis B
Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Published: February 22, 2023
Etiology and related clinical indicators of liver failure: an analysis of 3-year case data of Wuxi designated hospital for treatment of liver failure
Journal: Zhonghua wei zhong bing ji jiu yi xue
Published: December 26, 2022
Analyze the application rules and effects of "Four Elements, One Peptide, and Two Transplantations" based on bundle treatment in coronavirus disease 2019
Journal: Zhonghua wei zhong bing ji jiu yi xue
Published: November 15, 2022
Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: A cross-sectional study.
Journal: The Journal of infection
Published: June 26, 2022
The predictive value of liver failure-related etiology for clinical outcomes
Journal: Zhonghua wei zhong bing ji jiu yi xue
Published: April 07, 2022
Novel Molecular Therapeutics Targeting Signaling Pathway to Control Hepatitis B Viral Infection.
Journal: Frontiers in cellular and infection microbiology
Published: January 02, 2022
CCL19 enhances CD8+ T-cell responses and accelerates HBV clearance.
Journal: Journal of gastroenterology
Published: May 06, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026